Bacterial bioluminescence as a bioassay for mycotoxins

Area of Science:

• Environmental Toxicology
• Microbiology
• Analytical Chemistry

Background:

• Mycotoxins are toxic secondary metabolites produced by fungi, posing significant risks to human and animal health.
• Rapid and sensitive detection methods for mycotoxins are crucial for food safety and risk assessment.
• Bacterial bioluminescence offers a potential biosensing approach for toxicological evaluations.

Purpose of the Study:

• To evaluate the efficacy of bacterial bioluminescence as a toxicological assay for a panel of mycotoxins.
• To determine the sensitivity and time-dependent responses of the assay to various mycotoxins.

Main Methods:

• The study utilized the bioluminescent bacterium Photobacterium phosphoreum.
• Mycotoxin concentrations causing 50% light reduction (EC50) were determined for rubratoxin B, zearalenone, penicillic acid, citrinin, ochratoxin A, PR-toxin, aflatoxin B1, and patulin.
• Assays were conducted immediately and after 5 hours of bacterial reconstitution, with incubation times ranging from 5 to 20 minutes.

Main Results:

• Generally, lower mycotoxin concentrations were required to achieve EC50 at 5 hours post-reconstitution compared to immediate measurements.
• The assay demonstrated varying time-dependent responses: rubratoxin B required increasing concentrations over time, while citrinin, penicillic acid, patulin, and PR-toxin required decreasing concentrations.
• Zearalenone, aflatoxin B1, and ochratoxin A showed minimal change in required EC50 concentrations over time. The assay was most sensitive to patulin and least sensitive to rubratoxin B.

Conclusions:

• Bacterial bioluminescence is a viable method for mycotoxin toxicological assessment, exhibiting differential sensitivity and time-dependent effects.
• The assay's performance is influenced by the specific mycotoxin and incubation time, necessitating careful optimization for different analytes.
• Patulin demonstrated the highest sensitivity, while rubratoxin B showed the lowest, highlighting the assay's potential for targeted mycotoxin screening.